Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L7a pseudogene 71 (RPL7AP71) is a processed pseudogene located in the human genome, classified as a retrocopy of the parental RPL7A gene[2][9]. Processed pseudogenes arise from reverse transcription of mRNA and genomic integration but typically lack regulatory sequences and functional coding potential. RPL7AP71 does not encode a functional ribosomal protein and, like other processed pseudogenes, has no known physiological or disease-related function, nor is it a therapeutic target. The canonical functional gene, RPL7A, encodes the 60S ribosomal protein L7a, part of the large subunit of the cytoplasmic ribosome involved in protein synthesis[4][7]; however, RPL7AP71 itself is not expressed as a protein and has no established biological or pharmacological role[2][9][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7a pseudogene 71 (RPL7AP71).